Ferraioli D

ORCID: 0000-0003-3625-1285 · 5 papers in corpus · active 2020-2025

Study types

  • other 1

Condition tags

  • endometriosis 1
  • endometrioma 1
2025
The oncologist ·doi:10.1093/oncolo/oyae325

Ovarian clear cell carcinoma (OCCC) accounts for ~10% of all epithelial ovarian cancers and is considered a different entity from the more common high-grade serous ovarian carcinoma (HGSC), with distinct clinical presentations, different ri…

2025
Current issues in molecular biology ·doi:10.3390/cimb47090726

Clear cell ovarian carcinoma is a rare and aggressive histologic subtype of epithelial ovarian cancer, characterized by a chemoresistant phenotype and distinct immunogenomic features. Despite early-phase trials showing a limited response to…

2022
Annals of surgical oncology ·doi:10.1245/s10434-022-12353-y

BackgroundThe term uterine smooth muscle tumor of uncertain malignant potential (STUMP) indicates a rare, equivocal entity between benign leiomyomas and leiomyosarcomas. In the present study, we evaluated a comprehensive range of clinical, …

2021
Anatomical science international ·doi:10.1007/s12565-020-00553-z

The classical surgical anatomy of the female pelvis is limited by its gynecological oncological focus on the parametrium and burdened by its modeling based on personal techniques of different surgeons. However, surgical treatment of pelvic …

other 2020
Journal of clinical medicine ·doi:10.3390/jcm9124076

BACKGROUND: The assessment of ovarian reserve in the case of endometrioma is of pivotal importance for planning a tailored management. However, both the antral follicle count (AFC) and the antimüllerian hormone (AMH) dosage are subject to a…